Validation Study of RA-INF-Dx, a Multigene Molecular Test Used to Predict Non-Response to INfliximab Therapy

TerminatedOBSERVATIONAL
Enrollment

123

Participants

Timeline

Start Date

February 28, 2011

Primary Completion Date

October 31, 2012

Study Completion Date

October 31, 2012

Conditions
Rheumatoid Arthritis
Trial Locations (37)

Unknown

Location n°31, Mississauga - Chow

Location n°36, Ontario

Location n°34, Rimouski

Location n°33, Saskatchewan

Location n°35, Toronto

Location n°41, Amiens

Location n°13, Bobigny

Location n°39, Dreux

Location n°14, Grenoble

Location n°40, Meaux

Location n°25, Paris

Location n°37, Paris (Hop Bichat)

Location n°38, Strasbourg

Location n°6, Budapest

Location n°8, Budapest

Location n°7, Debrecen

Location n°10, Eger

Location n°9, Kistarcsa

Location n°15, Messina

Location n°16, Milan

Location n°17, Pisa

Location n°27, Kaunas

Location n°29, Klaipėda

Location n°30, Panevezys

Location n°28, Vilnius

Location n° 19, Bucharest

Location n°20, Bucharest

Location n°22, Bucharest

Location n°23, Bucharest

Location n°21, Cluj-Napoca

Location n°24, Iași

Location n°26, Iași

Location n°18, Timișoara

Location n°12, Banská Bystrica

Location n°11, Piešťany

Location n°3, Málaga

Location n°5, Oviedo

Sponsors
All Listed Sponsors
collaborator

Premier Research Group plc

UNKNOWN

collaborator

Theradis pharma

UNKNOWN

collaborator

Medpharmgene, Inc.

INDUSTRY

lead

TcLand Expression S.A.

INDUSTRY